PointState Capital’s Abbott ABT Stock Holding History

PointState Capital’s Portfolio ABT Stock Details ABT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-100,000	Closed	-$12M	–	127
2021 Q1	$12M	Buy	+100,000	New	+$11.8M	0.24%	72

Other funds holding ABT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

PointState Capital's ABT Position: Q4 2021 in Review

PointState Capital sold out of Abbott (ABT) in Q4 2021, closing a stake of 85,000 shares — an estimated $10M sold.

PointState Capital first reported a position in ABT in Q3 2016 and held it in 5 quarters. The position peaked at $20.9M in Q1 2021. 2,812 funds tracked by Wall St. Rank hold ABT as of Q4 2021.

PointState Capital reported no remaining Abbott position as of Q4 2021 after selling out during the quarter.
PointState Capital sold 85,000 Abbott shares in Q4 2021, an estimated $10M.
PointState Capital first reported a position in Abbott in Q3 2016 and held it in 5 quarters.
PointState Capital's Abbott position peaked at $20.9M in Q1 2021.
2,812 funds tracked by Wall St. Rank held Abbott as of Q4 2021.

Based on PointState Capital's 13F filing for Q4 2021, filed 11 Feb 2022.